These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37288156)

  • 21. Osteonecrosis of the jaw in patients treated with denosumab: A multicenter case series.
    Aljohani S; Gaudin R; Weiser J; Tröltzsch M; Ehrenfeld M; Kaeppler G; Smeets R; Otto S
    J Craniomaxillofac Surg; 2018 Sep; 46(9):1515-1525. PubMed ID: 29983309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful management of severe facial pain in patients with diffuse sclerosing osteomyelitis (DSO) of the mandible using disodium clodronate.
    Sugata T; Fujita Y; Myoken Y; Kiriyama T
    Int J Oral Maxillofac Surg; 2003 Oct; 32(5):574-5. PubMed ID: 14759123
    [No Abstract]   [Full Text] [Related]  

  • 23. Treating chronic diffuse sclerosing osteomyelitis of the mandible with saucerization and autogenous bone grafting.
    Ogawa A; Miyate H; Nakamura Y; Shimada M; Seki S; Kudo K
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Apr; 91(4):390-4. PubMed ID: 11312456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prompt clinical and biochemical response to denosumab in a young adult patient with craniofacial fibrous dysplasia.
    Eller-Vainicher C; Rossi DS; Guglielmi G; Beltramini GA; Cairoli E; Russillo A; Mantovani G; Spada A; Chiodini I
    Clin Cases Miner Bone Metab; 2016; 13(3):253-256. PubMed ID: 28228794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diffuse sclerosing osteomyelitis of the mandible.
    Jacobsson S
    Int J Oral Surg; 1984 Oct; 13(5):363-85. PubMed ID: 6437998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ.
    Khan AA; Morrison A; Kendler DL; Rizzoli R; Hanley DA; Felsenberg D; McCauley LK; O'Ryan F; Reid IR; Ruggiero SL; Taguchi A; Tetradis S; Watts NB; Brandi ML; Peters E; Guise T; Eastell R; Cheung AM; Morin SN; Masri B; Cooper C; Morgan SL; Obermayer-Pietsch B; Langdahl BL; Dabagh RA; Davison KS; Sándor GK; Josse RG; Bhandari M; El Rabbany M; Pierroz DD; Sulimani R; Saunders DP; Brown JP; Compston J;
    J Clin Densitom; 2017; 20(1):8-24. PubMed ID: 27956123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interventions for managing medication-related osteonecrosis of the jaw.
    Beth-Tasdogan NH; Mayer B; Hussein H; Zolk O
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012432. PubMed ID: 28983908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diffuse sclerosing osteomyelitis of the mandible: its characteristics and possible relationship to synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome.
    Suei Y; Taguchi A; Tanimoto K
    J Oral Maxillofac Surg; 1996 Oct; 54(10):1194-9; discussion 1199-200. PubMed ID: 8859238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of antiresorptive drugs on bony turnover in the jaw: denosumab compared with bisphosphonates.
    Ristow O; Gerngroß C; Schwaiger M; Hohlweg-Majert B; Kehl V; Jansen H; Hahnefeld L; Koerdt S; Otto S; Pautke C
    Br J Oral Maxillofac Surg; 2014 Apr; 52(4):308-13. PubMed ID: 24582013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and Radiographic Outcomes of Dental Implants in Patients Treated With Antiresorptive Drugs: A Consecutive Case Series.
    Otto S; Schnoedt EM; Troeltzsch M; Kaeppler G; Aljohani S; Liebermann A; Fliefel R
    J Oral Implantol; 2023 Feb; 49(1):39-45. PubMed ID: 35446931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diffuse sclerosing chronic osteomyelitis of the mandible].
    García Marín F; Iriarte Ortabe JI
    An Otorrinolaringol Ibero Am; 1996; 23(3):249-59. PubMed ID: 8712309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacteriologic and serologic investigation in diffuse sclerosing osteomyelitis (DSO) of the mandible.
    Jacobsson S; Dahlén G; Möller AJ
    Oral Surg Oral Med Oral Pathol; 1982 Nov; 54(5):506-12. PubMed ID: 6757825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diffuse sclerosing osteomyelitis of the mandible. Apropos of a case followed for more than 10 years].
    Boutault F; Alglave M; Gasquet F; Fabie M
    Rev Stomatol Chir Maxillofac; 1990; 91(1):41-6. PubMed ID: 2300782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RANKL and cathepsin K in diffuse sclerosing osteomyelitis of the mandible.
    Montonen M; Li TF; Lukinmaa PL; Sakai E; Hukkanen M; Sukura A; Konttinen YT
    J Oral Pathol Med; 2006 Nov; 35(10):620-5. PubMed ID: 17032395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful conservative treatment of jaw osteonecrosis caused by denosumab in patients with multiple bone metastasis.
    Ohga N; Sato J; Asaka T; Morimoto M; Yamazaki Y; Kitagawa Y
    J Oral Sci; 2018; 60(1):159-162. PubMed ID: 29576576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistent bone resorption lacunae on necrotic bone distinguish bisphosphonate-related osteonecrosis of jaw from denosumab-related osteonecrosis.
    Aoki K; Matsunaga S; Ito S; Shibahara T; Nomura T; Matsuzaki H; Abe S; Yamaguchi A
    J Bone Miner Metab; 2021 Sep; 39(5):737-747. PubMed ID: 33830351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medication-related osteonecrosis of the jaw associated with bisphosphonates and denosumab in osteoporosis.
    Bagan J; Peydró A; Calvo J; Leopoldo M; Jiménez Y; Bagan L
    Oral Dis; 2016 May; 22(4):324-9. PubMed ID: 26818808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bisphosphonate and denosumab-related osteonecrosis of the jaw: Epidemiology, diagnosis and management].
    Dupic G; Collangettes D; Dillies AF; Calvet L; Tournilhac O; Bay JO; Mahammedi H
    Bull Cancer; 2015 Dec; 102(12):1010-9. PubMed ID: 26607453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Denosumab in Patients With Fibrous Dysplasia Previously Treated With Bisphosphonates.
    Majoor BCJ; Papapoulos SE; Dijkstra PDS; Fiocco M; Hamdy NAT; Appelman-Dijkstra NM
    J Clin Endocrinol Metab; 2019 Dec; 104(12):6069-6078. PubMed ID: 31390018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diffuse sclerosing osteomyelitis (chronic tendoperiostitis) of the mandible. An 11-year follow-up report.
    Groot RH; van Merkesteyn JP; van Soest JJ; Bras J
    Oral Surg Oral Med Oral Pathol; 1992 Nov; 74(5):557-60. PubMed ID: 1437057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.